2020
DOI: 10.1007/s00467-020-04668-3
|View full text |Cite
|
Sign up to set email alerts
|

Cystatin C compared to serum creatinine as a marker of acute kidney injury in critically ill neonates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 16 publications
(11 citation statements)
references
References 31 publications
0
11
0
Order By: Relevance
“…Currently, the diagnosis of AKI is still based on the changes in urine volume and serum creatine (sCr), which are recognized as insensitive in early diagnosis (11). In recent decades, many specialists have attempted to identify ideal biomarkers to predict AKI, and an increasing number of novel biomarkers, such as kidney injury molecular-1 and cystatin C, have been investigated for their value in early AKI detection (12)(13)(14). However, for some reason, they have not yet been widely applied in clinical practice.…”
Section: Introductionmentioning
confidence: 99%
“…Currently, the diagnosis of AKI is still based on the changes in urine volume and serum creatine (sCr), which are recognized as insensitive in early diagnosis (11). In recent decades, many specialists have attempted to identify ideal biomarkers to predict AKI, and an increasing number of novel biomarkers, such as kidney injury molecular-1 and cystatin C, have been investigated for their value in early AKI detection (12)(13)(14). However, for some reason, they have not yet been widely applied in clinical practice.…”
Section: Introductionmentioning
confidence: 99%
“…Up until now, AKI has been defined by a rapid increase in serum Cr, a decrease in urine output, or both, indicating that Cr has a significantly predictive value for AKI [ 46 ]. Furthermore, Hidayati et al found that cystatin C was not superior to serum Cr in detecting neonatal AKI [ 47 ].…”
Section: Discussionmentioning
confidence: 99%
“… 30 Another report showed that serum Cys-C was also effective in diagnosing critically ill premature infants with AKI, with an SEN and SPE of 0.848, 0.618, and AUC of 0.849, but not better than SCr. 31 Compared with SCr, Cys-C seems to be a more specific and sensitive biomarker for urinary neutrophil gelatinase-associated lipocalin (NGIL) positive AKI in infants after cardiopulmonary bypass, with an SEN and SPE of 0.80 and 0.89 respectively and AUC of 0.87. 32 Additionally, a meta-analysis that included 24 articles (1948 children) showed the serum and urine levels of Cys-C were significantly higher in children with AKI.…”
Section: Discussionmentioning
confidence: 99%